Rossari BiotechNSE:ROSSARI -0.61%85 Days Payable is 59.54 as of Mar. 2026, which is 10% below its 10-year median of 66.08. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹1,000.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,555 Chemicals companies, Rossari Biotech ranks better than 54.98% on this metric.
The historical rank and industry rank for Rossari Biotech's Days Payable or its related term are showing as below:
NSE:ROSSARI'
s Days Payable Range Over the Past 10 Years
Min: 52 Med: 66.08 Max: 97.21
Current: 65.79
During the past 9 years, Rossari Biotech's highest Days Payable was 97.21. The lowest was 52.00. And the median was 66.08.
NSE:ROSSARI's Days Payable is ranked better than 54.98% of 1555
companies
in the Chemicals industry
Industry Median: 59.95
vs NSE:ROSSARI: 65.79
Rossari Biotech's Days Payable
declined
from Mar. 2025 (65.05) to Mar. 2026 (59.54).
It may suggest that Rossari Biotechaccelerated paying its suppliers.
Rossari Biotech Days Payable Related Terms
Rossari Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Rossari Biotech's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a Days Payable of 59.54 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rossari Biotech and its competitors. This is 10% below median its historical median of 66.08. Over the past decade, Rossari Biotech's Days Payable has ranged from 52.00 to 97.21. According to the industry distribution chart, Rossari Biotech ranks #700 out of 1555 companies in the Chemicals industry, placing it in the top 45%.
Is Rossari Biotech's Days Payable too high?
Rossari Biotech's current Days Payable of 59.54 is 10% below median its 10-year median of 66.08. Over the past 10 years, this metric has ranged from a low of 52.00 to a high of 97.21. The Chemicals industry median Days Payable is 59.95. Rossari Biotech's value of 59.54 is 0.7% below this industry median. Based on the distribution chart, Rossari Biotech ranks #700 out of 1555 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #700 out of 1555 companies for Days Payable. This puts Rossari Biotech in the upper half of its industry. The industry median Days Payable is 59.95. Rossari Biotech's value of 59.54 is 0.7% below this benchmark. Historically, Rossari Biotech's own Days Payable has ranged from 52.00 to 97.21 over the past decade. While the company's 10-year median is 66.08 vs. the industry median of 59.95, Rossari Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.95, based on 1,555 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Days Payable of 59.54 is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Days Payable is 59.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Days Payable is 59.54, which is 10% below median its own 10-year median of 66.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,000.66, compared to a current price of ₹523.90 — trading 47.6% below its estimated fair value. The current Days Payable is 59.54, which is 10% below median its 10-year median of 66.08 and 0.7% below the Chemicals industry median of 59.95. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Days Payable is 59.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹523.90 is trading 47.6% below its estimated GF Value™ of ₹1,000.66.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Days Payable: 59.54 (10% below median its 10-year median of 66.08)
GF Value™: ₹1,000.66 vs. price of ₹523.90 (47.6% below fair value)
Industry Position: 0.7% below the Chemicals median (#700 of 1555)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score
Get the complete analysis for NSE:ROSSARI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
